Extended Breastfeeding May Lower Risk of Certain Aggressive Breast Cancers
Longer breastfeeding and later age at first birth may reduce the risk of triple negative breast cancer, especially among high-risk groups. This research underscores the importance of supportive public health policies.
Recent research indicates that longer breastfeeding durations and later age at first childbirth are associated with reduced risk factors for triple negative breast cancer (TNBC), a particularly aggressive form of breast cancer. The study, published online on May 7 in npj Breast Cancer, highlights significant racial disparities and emphasizes the importance of public health policies that support breastfeeding.
Shorter durations of breastfeeding and younger age at first birth are linked to higher incidences of TNBC, with notable differences observed among various racial groups. Researchers from Yale University, led by Dr. Rachel Jaber Chehayeb, analyzed data to quantify how breastfeeding duration and age at first birth contribute to disparities in TNBC prevalence. They calculated the population-attributable fraction (PAF), finding that breastfeeding for less than six months accounts for 12% of TNBC cases among White women and 15% among Black women.
The findings suggest that policy measures promoting longer breastfeeding and addressing structural barriers can play a vital role in reducing the overall incidence of TNBC and narrowing racial disparities. Enhancing awareness of the protective benefits of breastfeeding, reforming workplace policies, and countering aggressive marketing from formula companies could encourage longer breastfeeding periods, ultimately leading to healthier populations.
The authors advocate for a cultural shift and supportive policies to increase breastfeeding rates, which could significantly impact breast cancer prevention efforts. The study underscores the critical role of public health initiatives in combating racial disparities and improving outcomes related to triple negative breast cancer.
For more detailed information, consult the original publication in npj Breast Cancer (DOI: 10.1038/s41523-025-00755-6).
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Potential Benefits of GLP-1 Receptor Agonists in Improving Lung Cancer Outcomes
New research reveals that GLP-1 receptor agonists, commonly used for diabetes and weight loss, may enhance lung cancer treatment outcomes by reducing tumor growth and improving survival rates.
Abnormal Fusion Protein Creates Cell Droplets That May Promote Childhood Brain Tumors
Scientists have uncovered how an abnormal fusion protein causes cell droplet formation, potentially driving childhood brain tumors like ependymoma. This discovery opens new possibilities for targeted therapies in difficult-to-treat cancers.
Innovative Wi-Fi-Based Sleep Monitoring Offers Non-Intrusive and Precise Insights
Discover how Wi-Fi signals can be leveraged to monitor sleep patterns accurately and non-intrusively, offering a promising alternative to traditional sleep study methods.
ESC Urges a Cultural Transformation to Address the Link Between Mental Health and Cardiovascular Disease
The European Society of Cardiology calls for a major cultural change in healthcare, emphasizing integrated approaches to manage the interconnected risks of mental health conditions and cardiovascular disease for better patient outcomes.